Creso Pharma Shares Up 20% as UN Eases Stance on Cannabis

By ,

Tiny pot stock Creso Pharma Ltd [ASX:CPH] is soaring today. The CPH share price is trading 22.22% higher at time of writing.

A huge boost for investors as the market eyes up this fascinating stock.

However, what is far more fascinating is the reason for Creso’s surge today. Rising higher on the back of a surprising and landmark decision from the UN…

Cannabis reclassified for good

As Creso notes, the UN has decided to reclassify cannabis. Removing it from the Schedule IV status that it has held since 1961.

Under Schedule IV, cannabis was treated as one of the most dangerous drugs. Sitting alongside other narcotics such as heroin. A severe judgement to say the least.

Now though, just over half a century later, the UN has turned a new leaf.

Cannabis will now move to Schedule I — the least restrictive schedule of the four. And while that still means the UN isn’t quite ready to remove it from the list entirely, it is a huge development. One that suggests the organisational body may finally be recognising cannabis’ medicinal potential.

For pot stocks like Creso, this is a huge sentimental win.

It proves yet again that the tide is continuing to turn. With more groups, governments, and individuals slowly realising the potential of this demonised drug. A drug that is rapidly cultivating a sizeable industry.

As Creso Director Boaz Wachtel notes:

The UN ruling to reclassify cannabis is a landmark decision and paves the way for the relaxing of cannabis drug classifications in large markets across the world.

The results of this vote follows 60 years of status quo, three years of scientific review by the world’s leading health organisations, two years of diplomatic discussions and considerable lobbying from NGOs.

I am proud and privileged to have been a part of a small group of dedicated activists that have fought for decades to reschedule cannabis. I am very confident that this decision will unlock a number of near term opportunities for Creso Pharma, and I look forward to working with the Board and management to unlock further value for shareholders.

For shareholders that is certainly welcome news. As for how and when Wachtel hopes to ‘unlock’ this value though, remains to be seen.

After all, Creso investors have had a rough year. And now, more than ever, management needs to turn things around.

Hopefully this decision will help provide a catalyst for this goal.

What’s next for Creso?

The ongoing challenge for Creso is to continue to market and sell its established products. Largely revolving around a range of pharmaceutical and nutraceutical goods.

However, Creso also has cannabis-based products for cosmetics and animal wellbeing as well. So, they certainly have plenty of avenues to explore. It is simply a matter of seeing what sticks and what doesn’t.

With a little help from today’s exposure, they may be closer to making that happen.

Regards,

Ryan Clarkson-Ledward,
For Money Morning

PS: For more pot stock news, as well all things investing related, check out our daily e-letter Money Morning. Bringing you all the latest news that the mainstream isn’t fit to cover. Including insights to help you on your investing journey. For more info, and to sign up for free, click here.

About Ryan Clarkson-Ledward

Ryan Clarkson-Ledward is an Editor at Money Morning.

Ryan holds degrees in both communication and international business. He helps bring Money Morning readers the latest market updates, both locally and abroad. Ryan tackles all the issues investors need to know about that the mainstream media neglects.

Ryan is also the Editor…

ASX 200 News Weekly Wrap — Magnis, Creso, Cettire, Crown and Commonwealth Bank

We review this week’s ASX news, from MNS and CPH getting caught up in ASIC probes to CBA shares tanking on their latest quarterly.

Why is the Creso Share Price Falling? (ASX:CPH)

The Creso Pharma [ASX:CPH] share price is falling as ASIC probes EverBlu Capital, whose executive chairman also serves as CPH’s non-executive chair and co-founder.  

Creso Pharma Shares Jumps 12% after Securing New Purchase Orders (ASX:CPH)

The Creso Pharma [ASX:CPH] shares soared in early morning trade after the company announced its wholly-owned Canadian subsidiary, Mernova, secured over $800,000 in new purchase orders.

Creso Pharma Secures New Win in Canada — Shares Up 8% (ASX:CPH)

Aussie pot stock Creso Pharma [ASX:CPH] share price is on the up today. The share price is currently trading 8% higher at time of writing.

Creso Share Price Surges 9% on June Quarter Results (ASX:CPH)

The Creso Pharma Ltd [ASX:CPH] share price is up 9% after the release of its June quarter results. The CPH share price were trading for 12 cents at time of writing…

Creso Share Price Up as Its Subsidiary Announces New MOU (ASX:CPH)

Pot stock Creso Pharma [ASX:CPH] is on the up today. Shares are trading 1.54% higher as the company announced some new developments from its Canadian subsidiary: Halucenex…